Regulus Therapeutics Inc (RGLS) Insider Trading
- $20,106,487.22
- $44,140,926.59
- Jan. 18, 2024
- Isis Pharmaceuticals Inc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 18, 2014 | Director | 5,000 | $6.80 | Sell | $34,000.00 | |
| July 17, 2014 | Director | 5,000 | $6.58 | Sell | $32,900.00 | |
| July 16, 2014 | Director | 3,500 | $6.59 | Sell | $23,065.00 | |
| July 11, 2014 | Director | 1,750 | $6.48 | Sell | $11,340.00 | |
| July 10, 2014 | Director | 4,500 | $6.69 | Sell | $30,105.00 | |
| July 9, 2014 | Director | 1,800 | $7.08 | Sell | $12,744.00 | |
| Feb. 4, 2014 | major shareholder | 1,303,780 | $7.67 | Buy | $9,999,992.60 | |
| Jan. 21, 2014 | Insider | 4,421 | $8.09 | Sell | $35,765.89 | |
| Jan. 17, 2014 | Insider | 4,479 | $8.15 | Sell | $36,503.85 | |
| Jan. 16, 2014 | Insider | 1,100 | $8.03 | Sell | $8,833.00 | |
| Jan. 2, 2014 | CEO | 3,505 | $7.25 | Sell | $25,411.25 | |
| Oct. 10, 2012 | Director | 750,000 | $4.00 | Buy | $3,000,000.00 |
Insiders are both buying and selling Regulus Therapeutics Inc stock.
The insider traders at Regulus Therapeutics Inc are: Isis Pharmaceuticals Inc, Joseph P Hagan, Alnylam Pharmaceuticals, Inc., Christopher Ray Aker, Kleanthis G Xanthopoulos, William H Rastetter, Daniel R Chevallard, Neil W Gibson, Stelios Papadopoulos, Neil Gibson, Kleanthis Xanthopoulos, Bruce L A Carter, Pascale Witz, Paul Edward Walker, Peter J Barris, Sanofi, Stanley T Crooke, Kathryn J Collier, Denis Drygin, and Crispina Calsada
The most active insider trader at Regulus Therapeutics Inc is Isis Pharmaceuticals Inc with 34 trades.
Isis Pharmaceuticals Inc has sold the most Regulus Therapeutics Inc stock with a total value of $28,417,089.94.
Sanofi has bought the most Regulus Therapeutics Inc stock with a total value of $19,999,985.20.
The most recent insider trade for Regulus Therapeutics Inc was on Jan. 18, 2024.
The single biggest insider buy for Regulus Therapeutics Inc was from Sanofi with a total value of $9,999,992.60 on Feb. 4, 2014.
The single biggest insider sell for Regulus Therapeutics Inc was from Isis Pharmaceuticals Inc with a total value of $20,393,811.34 on Nov. 3, 2014.